Assessment of HER-2/neu Status in Breast Cancer
Authors:
- Momin T. SiddiquiMSMomin T. Siddiqui
- Frank H. WiansFWFrank H. Wians
- Linda HynanLHLinda Hynan
Open Access
- 1 October 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (4) , 495-503
Abstract
This retrospective study of formalin-fixed infiltrating breast cancer specimens compared manual immunohistochemical assay with a new image analyzer–aKeywords
This publication has 23 references indexed in Scilit:
- HER-2/neu Gene Amplification Compared With HER-2/neu Protein Overexpression and Interobserver Reproducibility in Invasive Breast CarcinomaAmerican Journal of Clinical Pathology, 2000
- Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assaysJournal of Clinical Pathology, 2000
- Immunohistochemical Determination of HER-2/neu Expression in Invasive Breast CarcinomaAmerican Journal of Clinical Pathology, 2000
- HER‐2/ neu Signal Transduction in Human Breast and Ovarian CancerStem Cells, 1997
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.Proceedings of the National Academy of Sciences, 1992
- Humanization of an anti-p185HER2 antibody for human cancer therapy.Proceedings of the National Academy of Sciences, 1992
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12–21.32Genomics, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987